1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics, July 2016

Biotechnology Analysis & Statistics, July 2016

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Publishers

All regions

1-30 of about 6 300 reports

Purchase Reports From Reputable Market Research Publishers

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cance ...

  • Industries : Cancer, Pathology
  • Countries : United States
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016’, provides an overview of the Retinitis Pigmentosa ...

  • Industries : Therapy, Pathology, Research and Development, Biological Therapy
  • Countries : United States
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hospital Acquired Methicillin-Resistant Staphylococcus ...

  • Industries : Therapy
  • Countries : World, United Kingdom, United States
Poliomyelitis - Pipeline Review, H1 2016

Poliomyelitis - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Poliomyelitis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Poliomyelitis - Pipeline Review, H1 2016’, provides an overview of the Poliomyelitis pipeline landscape. The report provides ...

  • Industries : Pathology, Therapy, Biopharmaceutical, Healthcare
  • Countries : United States, World
Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Sangamo BioSciences, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sangamo BioSciences, ...

  • Industries : Research and Development, Biological Therapy, Therapy, Pathology
  • Countries : United States
Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016

Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016’, provides ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, ...

  • Industries : Pathology, Therapy, Pharmaceutical, Healthcare
  • Countries : United States
Toxoplasmosis - Pipeline Review, H1 2016

Toxoplasmosis - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Toxoplasmosis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Toxoplasmosis - Pipeline Review, H1 2016’, provides an overview of the Toxoplasmosis pipeline landscape. The report provides ...

  • Industries : Pathology, Biopharmaceutical, Therapy
  • Countries : World
Nanotherapeutics, Inc. - Product Pipeline Review - 2016

Nanotherapeutics, Inc. - Product Pipeline Review - 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Nanotherapeutics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Nanotherapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Nanotherapeutics, Inc.’s ...

  • Industries : Therapy
  • Countries : United States
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, Therapy, Healthcare, Pharmaceutical
  • Countries : United States
Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Streptococcal Pneumonia - Pipeline Review, H1 2016

Streptococcal Pneumonia - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Streptococcal Pneumonia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Streptococcal Pneumonia - Pipeline Review, H1 2016’, provides an overview of the Streptococcal Pneumonia pipeline ...

  • Industries : Pathology, Biopharmaceutical, Therapy, Healthcare, Biotechnology
  • Countries : World
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016’, provides an overview of the Live ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016’, provides an overview of the Herpes ...

  • Industries : Therapy, Biopharmaceutical, Research and Development, Pharmaceutical, Biotechnology, Pathology
  • Countries : United States
Age Related Macular Degeneration - Pipeline Review, H1 2016

Age Related Macular Degeneration - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Age Related ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Cervical Intraepithelial Neoplasia (CIN) - Pipeline Review, H1 2016’, provides an overview of ...

  • Industries : Therapy, Biopharmaceutical, Biological Therapy, Biotechnology
  • Countries : United States
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2016’, provides an overview of the Metachromatic ...

  • Industries : Mental Health
  • Countries : United States, World
Global Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

Global Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. VPGMarketResearch.com's new report is a study of the major business opportunities emerging in the global cance ...

  • Industries : Biopharmaceutical
  • Countries : United States
Europe Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

Europe Cancer Diagnostics Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

  • $ 12 800
  • Industry report
  • July 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

  • Industries : Biopharmaceutical
Tumor Markers: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Tumor Markers: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 12 800
  • Industry report
  • June 2016
  • by Venture Planning Group

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. Summary This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the ...

  • Industries : Biopharmaceutical
Cancer Diagnostics Market:  France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics Market: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 12 800
  • Industry report
  • June 2016
  • by Venture Planning Group

This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The ...

  • Industries : Biopharmaceutical
  • Countries : France
2016-2020 Europe Tumor Marker Testing Market: Supplier Shares by Test, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities--France, Germany, Italy, Spain, UK

2016-2020 Europe Tumor Marker Testing Market: Supplier Shares by Test, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities--France, Germany, Italy, Spain, UK

  • $ 12 800
  • Industry report
  • May 2016
  • by Venture Planning Group

Complete report $19,700.DataPack (test volumes, sales forecasts, supplier shares) $12,800.Summary This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the majo ...

  • Industries : Biopharmaceutical
Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis

  • $ 9 495
  • Industry report
  • May 2016
  • by Global Data

Immuno-Oncology Strategic Insight - Multi-Indication And Market Size Analysis Summary GlobalData estimates that the total IO market will be worth approximately $14 billion in 2019, rising to $34 billion ...

  • Industries : Therapy, Cancer, Pathology, Pharmaceutical, Biotechnology
Medical Affiars Reputation: Multiple Sclerosis (US)

Medical Affiars Reputation: Multiple Sclerosis (US)

  • $ 6 320
  • Industry report
  • June 2016
  • by Firstword Pharma

MS medical affairs: oral therapies outperforming in the US. How does your team measure up? In the US multiple sclerosis (MS) market, medical affairs teams for oral therapies outperform their platform-therapy ...

  • Industries : Biopharmaceutical
Medical Affiars Reputation: Multiple Sclerosis (EU5)

Medical Affiars Reputation: Multiple Sclerosis (EU5)

  • $ 6 320
  • Industry report
  • June 2016
  • by Firstword Pharma

MS medical affairs: oral therapies outperforming in Europe. How does your team measure up? In Europe’s Multiple Sclerosis (MS) market, medical affairs teams for oral therapies outperform their platform-therapy ...

  • Industries : Biopharmaceutical
  • Countries : Europe
Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies

  • $ 6 995
  • Industry report
  • June 2016
  • by GBI Research

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies Summary Hematological malignancies are a class of cancer that affect the ...

  • Industries : Cancer, Pathology
  • Countries : World
Cardiac Biomarkers: Technologies and Global Markets

Cardiac Biomarkers: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2016
  • by BCC Research

This BCC Research report provides a comprehensive analysis of the cardiac biomarker market and its trends from 2014 through 2020. It details the history and current state of cardiovascular diseases (CVDs), ...

  • Industries : Genomics
  • Countries : World
Biomarkers: Technologies and Global Markets

Biomarkers: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2016
  • by BCC Research

This BCC Research study provides a comprehensive analysis of biomarkers on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to overall ...

  • Industries : Genomics
  • Countries : World
DNA Sequencing: Emerging Technologies and Applications

DNA Sequencing: Emerging Technologies and Applications

  • $ 6 650
  • Industry report
  • May 2016
  • by BCC Research

This BCC Research report provides a comprehensive discussion of sequencing technologies, market applications, industry structure, important clinical sequencing initiatives, global markets, and companies. ...

  • Industries : Genomics
  • Countries : World
The Global Market for Stem Cells

The Global Market for Stem Cells

  • $ 6 650
  • Industry report
  • May 2016
  • by BCC Research

This BCC Research report provides implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and important ...

  • Industries : Biological Therapy
  • Countries : World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.